摘要
多项临床试验证明,核素心肌灌注显像在冠心病诊断、危险度分层、预后判断、病人处理方案等方面具有突出的作用和优越的价值。在ACC/AHA(美国心脏病学院/美国心脏学会)有关冠心病和核心脏病学指南中,心肌灌注显像的上述作用得到了充分肯定。合理应用该项技术可以提高对冠心病诊断、处理的整体水平,并使有限的医疗资源得到更合理利用,这在我国目前显得十分迫切和需要。
Many clinical trials have proven nuclear myocardial perfusion imaging may take a key role in diagnoses, risk stratification and management of coronary artery disease. These values of myocardial perfusion imaging have been stressed in the guidelines of ACC/AHA about coronary artery disease and nuclear cardiology. The appropreciate use of myocardial perfusion imaging may increase our ability of managing with coronary disease and better utilization of medical resources in China.
出处
《国外医学（放射医学核医学分册）》
2004年第3期97-100,共4页
Foreign Medical Sciences(Section of Radiation Medicine and Nuclear Medicine)
关键词
冠心病
心肌灌注显像
危险度分层
预后
coronary artery disease
myocardial perfusion imaging
risk stratification
prognosis
